Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
Hyderabad, 17th December, 2020: A preliminary laboratory based research conducted by Dr. HSJ Institute of Dental Sciences, Panjab University in collaboration with CSIR-Institute of Microbial Technology (IMTECH) revealed that one of the most routinely used mouth rinses, Chlorhexidine, has proven to be effective against SARS CoV2. The study, titled “Chlorhexidine: An effective anti-Covid mouth rinse” was supported by Dr. Reddy’s Laboratories and Design Innovation Centre, Panjab University. Studies have shown that SARS CoV 2 virus colonizes in the oral and nasal cavities. Mouth rinses can be an effective way to reduce the colonization and possibly reduce the transmission of infection. The public at large has become very conscious about oral hygiene in these COVID times so as to prevent SARS CoV2 infection. Chlorhexidine is a gold standard mouth rinse due to its broad spectrum bactericidal and virucidal properties. This study was aimed at providing an insight into the effectiveness of Chlorhexidine 0.2% against SARS CoV2, through an analysis in a laboratory. It was observed that, chlorhexidine digluconate mouth rinses in 0.2% concentration kill more than 99.9% of SARS CoV 2 virus in minimal contact time of 30 seconds. Dr. Ashish Jain from Dr. HSJ Institute of Dental Sciences, the author of the study, said “Our study revealed that a mouth rinse with the required concentration of Chlorhexidine killed coronavirus within 30 seconds after being exposed in a laboratory. These are the initial results from the lab studies and need to be verified through clinical studies. We are indeed grateful to Dr. Reddy’s Laboratories and Design Innovation Centre, Panjab University for providing support in conducting this preliminary study successfully.
About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com
About Panjab University
Panjab University (PU) is a central university located in Chandigarh, India. It was established in 1882 as University of Punjab at Lahore (now in Pakistan) and later relocated to Chandigarh in 1947. It has been Accredited with a CGPA of 3.35 on a four-point scale at A Grade valid upto 24/06/2022. The university has 78 teaching and research departments and 10 centres / chairs at the main campus located at Chandigarh. It has 188 affiliated colleges spread over the eight districts of Punjab state and union-territory of Chandigarh, with Regional Centres at Muktsar, Ludhiana and Hoshiarpur cities in Punjab state. Spread over 550 acres (2.2 km2), the campus comprises of the main administrative and academic buildings, health centre, a sports complex, hostels and residential housing for staff. https://puchd.ac.in/
